775 logo

CK Life Sciences Int'l., (Holdings) Inc. Stock Price

SEHK:775 Community·HK$8.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

775 Share Price Performance

HK$0.89
0.44 (97.78%)
HK$0.89
0.44 (97.78%)
Price HK$0.89

775 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slightly overvalued with very low risk.

2 Risks
0 Rewards

CK Life Sciences Int'l., (Holdings) Inc. Key Details

HK$5.5b

Revenue

HK$3.8b

Cost of Revenue

HK$1.7b

Gross Profit

HK$2.0b

Other Expenses

-HK$278.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.029
30.71%
-5.07%
160.8%
View Full Analysis

About 775

Founded
1999
Employees
1935
CEO
Lee Yuen
WebsiteView website
www.ck-lifesciences.com

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, the company distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food sectors; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.

Recent 775 News & Updates

CK Life Sciences Int'l. (Holdings) (HKG:775) Is Carrying A Fair Bit Of Debt

Nov 14
CK Life Sciences Int'l. (Holdings) (HKG:775) Is Carrying A Fair Bit Of Debt

Recent updates

No updates